(S1 (S (S (NP (NP (JJ Hypoxia-inducible) (NN factor) (CD 1) (NN activation)) (PP (IN by) (NP (JJ aerobic) (NN glycolysis)))) (VP (VBZ implicates) (NP (DT the) (NN Warburg) (NN effect)) (PP (IN in) (NP (NN carcinogenesis))))) (. .)))
(S1 (S (S (NP (NN Cancer) (NNS cells)) (VP (VBP display) (NP (NP (NP (JJ high) (NNS rates)) (PP (IN of) (NP (JJ aerobic) (NN glycolysis)))) (, ,) (NP (NP (DT a) (NN phenomenon)) (VP (VBN known) (ADVP (RB historically)) (PP (IN as) (NP (DT the) (NN Warburg) (NN effect)))))))) (. .)))
(S1 (S (S (NP (NP (NP (NN Lactate)) (CC and) (NP (NN pyruvate))) (, ,) (NP (NP (DT the) (NN end) (NNS products)) (PP (IN of) (NP (NN glycolysis)))) (, ,)) (VP (VBP are) (ADVP (RB highly)) (VP (VBN produced) (PP (IN by) (NP (NN cancer) (NNS cells))) (PP (ADVP (RB even)) (IN in) (DT the) (NN presence) (IN of) (NP (NN oxygen)))))) (. .)))
(S1 (S (S (NP (NP (JJ Hypoxia-induced) (NN gene) (NN expression)) (PP (IN in) (NP (NN cancer) (NNS cells)))) (VP (VBZ has) (VP (VBN been) (VP (VBN linked) (PP (TO to) (NP (JJ malignant) (NN transformation))))))) (. .)))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (NP (NN lactate)) (CC and) (NP (NN pyruvate))) (VP (VBP regulate) (NP (JJ hypoxia-inducible) (NN gene) (NN expression)) (ADVP (RB independently) (PP (IN of) (NP (NN hypoxia)))) (PP (IN by) (S (VP (VBG stimulating) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NP (JJ hypoxia-inducible) (NN Factor) (NN 1alpha)) (PRN (-LRB- -LRB-) (NP (NN HIF-1alpha)) (-RRB- -RRB-)))))))))))))) (. .)))
(S1 (S (PP (IN In) (NP (NP (JJ human) (NNS gliomas)) (CC and) (NP (JJ other) (NN cancer) (NN cell) (NNS lines)))) (, ,) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN HIF-1alpha) (NN protein))) (PP (IN under) (NP (JJ aerobic) (NNS conditions)))) (VP (VBZ requires) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN glucose))) (PP (TO to) (NP (NN pyruvate))) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ prevents) (NP (NP (DT the) (JJ aerobic) (NN degradation)) (PP (IN of) (NP (NN HIF-1alpha) (NN protein))))) (, ,) (VP (VBZ activates) (NP (NN HIF-1) (NN DNA) (NN binding) (NN activity))) (, ,) (CC and) (VP (VBZ enhances) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ several) (JJ HIF-1-activated) (NNS genes)) (PP (VBG including) (NP (NP (NN erythropoietin)) (, ,) (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (, ,) (NP (NN glucose) (NN transporter) (CD 3)) (, ,) (CC and) (NP (NN aldolase) (NN A))))))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS findings)) (VP (VP (VBP support) (NP (NP (DT a) (JJ novel) (NN role)) (PP (IN for) (NP (NN pyruvate))) (PP (IN in) (NP (JJ metabolic) (NN signaling))))) (CC and) (VP (VBP suggest) (NP (NP (DT a) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NP (JJ high) (NNS rates)) (PP (IN of) (NP (JJ aerobic) (NN glycolysis)))) (VP (MD can) (VP (VB promote) (NP (NP (DT the) (JJ malignant) (NP (NN transformation)) (CC and) (NP (NN survival))) (PP (IN of) (NP (NN cancer) (NNS cells)))))))))))) (. .)))
